Cullen L et al. |
Selective cyclooxygenase-2 inhibition by nimesulide in man. |
1998 |
J. Pharmacol. Exp. Ther. |
pmid:9808683
|
Bosetti F et al. |
Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. |
2003 |
J. Neurochem. |
pmid:12694395
|
Romano M et al. |
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide. |
2000 |
J. Investig. Med. |
pmid:10822898
|
Morrow JD et al. |
Increased formation of thromboxane in vivo in humans with mastocytosis. |
1999 |
J. Invest. Dermatol. |
pmid:10417625
|
Foegh ML et al. |
Urinary thromboxane A2 metabolites in patients presenting in the emergency room with acute chest pain. |
1994 |
J. Intern. Med. |
pmid:8308478
|
Laffi G et al. |
Defective aggregation in cirrhosis is independent of in vivo platelet activation. |
1996 |
J. Hepatol. |
pmid:8738730
|
Cesari M et al. |
Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study. |
2012 |
J. Gerontol. A Biol. Sci. Med. Sci. |
pmid:22389462
|
Vazzana N et al. |
Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress. |
2012 |
J. Clin. Endocrinol. Metab. |
pmid:22761461
|
Böhm E et al. |
11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. |
2004 |
J. Biol. Chem. |
pmid:14668348
|
Gremmel T et al. |
Differential impact of inflammation on six laboratory assays measuring residual arachidonic acid-inducible platelet reactivity during dual antiplatelet therapy. |
2013 |
J. Atheroscler. Thromb. |
pmid:23739624
|
Yi X et al. |
Platelet response to aspirin in Chinese stroke patients is independent of genetic polymorphisms of COX-1 C50T and COX-2 G765C. |
2013 |
J. Atheroscler. Thromb. |
pmid:22972377
|
Cuiper LL et al. |
Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2. |
1996 |
J. Appl. Physiol. |
pmid:8847301
|
Ciabattoni G et al. |
Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty. |
1993 |
J. Am. Coll. Cardiol. |
pmid:8473644
|
Benowitz NL et al. |
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. |
1993 |
J. Am. Coll. Cardiol. |
pmid:7691912
|
Santilli F et al. |
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. |
2006 |
J. Am. Coll. Cardiol. |
pmid:16412866
|
Stanke-Labesque F et al. |
Increased urinary leukotriene E4 excretion in obstructive sleep apnea: effects of obesity and hypoxia. |
2009 |
J. Allergy Clin. Immunol. |
pmid:19596146
|
Lindström T et al. |
The effect of unreamed and reamed intramedullary nailing on the urinary excretion of prostacyclin and thromboxane A2 metabolites in patients with tibial shaft fractures. |
1998 |
J Trauma |
pmid:9783614
|
Thomson VS et al. |
Aspirin resistance in Indian patients with coronary artery disease and cardiovascular events. |
2009 Oct-Dec |
J Postgrad Med |
pmid:20083870
|
Pape HC et al. |
Does the reamer type influence the degree of lung dysfunction after femoral nailing following severe trauma? An animal study. |
1994 |
J Orthop Trauma |
pmid:7965291
|
Schwartz JI et al. |
Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet. |
2007 |
J Clin Pharmacol |
pmid:17925592
|
Roethig HJ et al. |
A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. |
2008 |
J Clin Pharmacol |
pmid:18319361
|
Lauring B et al. |
Laropiprant in combination with extended-release niacin does not alter urine 11-dehydrothromboxane B2, a marker of in vivo platelet function, in healthy, hypercholesterolemic, and diabetic subjects. |
2009 |
J Clin Pharmacol |
pmid:19833861
|
Vazzana N et al. |
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype. |
2013 |
J Am Heart Assoc |
pmid:23557750
|
Kakouros N et al. |
Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery. |
2016 |
J Am Heart Assoc |
pmid:27068626
|
Lattanzio S et al. |
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. |
2014 |
J Am Heart Assoc |
pmid:25037197
|
Santilli F et al. |
Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment. |
2014 |
J Am Heart Assoc |
pmid:25037196
|
Shen L et al. |
In vivo oxidation, platelet activation and simultaneous occurrence of natural immunity in atherosclerosis-prone mice. |
2011 |
Isr. Med. Assoc. J. |
pmid:21845968
|
Uyama O et al. |
Urinary 11-dehydro-thromboxane B2: a quantitative index of platelet activation in cerebral infarction. |
1992 |
Intern. Med. |
pmid:1392173
|
De Candia E et al. |
Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X. |
2005 |
Int. J. Cardiol. |
pmid:15837078
|
Oosaki R et al. |
Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in patients with spontaneous asthma attacks. |
1997 |
Int. Arch. Allergy Immunol. |
pmid:9414142
|
Sadilkova L et al. |
The effect of selected pre-analytical phase variables on plasma thromboxane Aâ‚‚ measurements in humans. |
2013 |
Int J Lab Hematol |
pmid:22908995
|
Alusik S et al. |
The inhibitory effect of statins on urinary 11-dehydrothromboxane levels. |
2010 |
Int Angiol |
pmid:20502413
|
Minuz P et al. |
Determinants of platelet activation in human essential hypertension. |
2004 |
Hypertension |
pmid:14656953
|
Ikonomidis I et al. |
Reduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor. |
2004 |
Heart |
pmid:15020512
|
Kitano A et al. |
Increased 11-dehydrothromboxane B2 in migraine: platelet hyperfunction in patients with migraine during headache-free period. |
1994 |
Headache |
pmid:8002323
|
Oishi M and Mochizuki Y |
beta-Thromboglobulin and 11-dehydrothromboxane B in tension-type headache. |
1998 |
Headache |
pmid:15613179
|
Ferrante E et al. |
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. |
2010 |
Free Radic. Biol. Med. |
pmid:20541603
|
Guagnano MT et al. |
Determinants of platelet activation in hypertensives with microalbuminuria. |
2009 |
Free Radic. Biol. Med. |
pmid:19280705
|
Gautier-Veyret E et al. |
Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosis. |
2013 |
Eur. Respir. J. |
pmid:23060635
|
Hayashi M et al. |
Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia. |
2002 Nov-Dec |
Eur. J. Haematol. |
pmid:12460234
|
Laleman W et al. |
A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited. |
2006 |
Eur. J. Clin. Invest. |
pmid:16620286
|
Lahoz C et al. |
Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. |
1997 |
Eur. J. Clin. Invest. |
pmid:9352251
|
Ross S et al. |
Association of cyclooxygenase-2 genetic variant with cardiovascular disease. |
2014 |
Eur. Heart J. |
pmid:24796340
|
Wang Z et al. |
Aspirin resistance in off-pump coronary artery bypass grafting. |
2012 |
Eur J Cardiothorac Surg |
pmid:21636287
|
Zisman E et al. |
Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients. |
2010 |
Eur J Anaesthesiol |
pmid:20035230
|
Boizel R et al. |
Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetes. |
2010 |
Diabetologia |
pmid:20535444
|
Yassine HN et al. |
Clinical determinants of aspirin resistance in diabetes. |
2010 |
Diabetes Res. Clin. Pract. |
pmid:20719400
|
Katoh K |
Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus. |
1992 |
Diabetes Res. Clin. Pract. |
pmid:1478157
|
Rautanen M et al. |
Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs. |
1997 |
Crit. Care Med. |
pmid:9233750
|
Nagase T et al. |
Intravenous bolus of prednisolone decreases 15-hydroxyeicosatetraenoic acid formation in the rat model of acid aspiration. |
1991 |
Crit. Care Med. |
pmid:2055084
|
Schlit AF et al. |
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives. |
1995 |
Contraception |
pmid:7750285
|
Nüsing RM et al. |
Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. |
2001 |
Clin. Pharmacol. Ther. |
pmid:11673754
|
Renda G et al. |
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. |
2006 |
Clin. Pharmacol. Ther. |
pmid:16952493
|
Lee CR et al. |
Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study. |
2008 |
Clin. Pharmacol. Ther. |
pmid:17495879
|
Cipollone F et al. |
Effects of nabumetone on prostanoid biosynthesis in humans. |
1995 |
Clin. Pharmacol. Ther. |
pmid:7554708
|
Oosaki R et al. |
Correlation among urinary eosinophil protein X, leukotriene E4, and 11-dehydrothromboxane B2 in patients with spontaneous asthmatic attack. |
1998 |
Clin. Exp. Allergy |
pmid:9761018
|
Gonçalves LH et al. |
Acetylsalicylic acid therapy: influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels. |
2014 |
Clin. Chim. Acta |
pmid:24316050
|
Gonçalves LH et al. |
Urinary 11-dehydro thromboxane Bâ‚‚ levels in type 2 diabetic patients before and during aspirin intake. |
2011 |
Clin. Chim. Acta |
pmid:21510926
|
Lowe FJ et al. |
Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers. |
2009 |
Clin. Chem. Lab. Med. |
pmid:19676143
|
Djurup R et al. |
Rapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry. |
1993 |
Clin. Chem. |
pmid:8252718
|
Karon BS et al. |
Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. |
2008 |
Clin. Chem. |
pmid:18420732
|
Fiorucci S et al. |
NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. |
2002 |
Circulation |
pmid:12473561
|
Rouvier J et al. |
Aspirin resistance. |
2002 |
Circulation |
pmid:12473569
|
Minuz P et al. |
Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. |
2002 |
Circulation |
pmid:12451006
|
Hennekens CH et al. |
Terms and conditions: semantic complexity and aspirin resistance. |
2004 |
Circulation |
pmid:15381661
|
Belton O et al. |
Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. |
2000 |
Circulation |
pmid:10952950
|
Reilly M et al. |
Modulation of oxidant stress in vivo in chronic cigarette smokers. |
1996 |
Circulation |
pmid:8964113
|
Davì G et al. |
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. |
2003 |
Circulation |
pmid:12810609
|
Patrignani P et al. |
Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. |
2000 |
Circulation |
pmid:10920066
|
Davì G et al. |
Oxidative stress and platelet activation in homozygous homocystinuria. |
2001 |
Circulation |
pmid:11535567
|
Maree AO and Fitzgerald DJ |
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. |
2007 |
Circulation |
pmid:17452618
|
Cipollone F et al. |
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. |
2002 |
Circulation |
pmid:12135935
|
Capone ML et al. |
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. |
2004 |
Circulation |
pmid:15037526
|
Eikelboom JW et al. |
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. |
2002 |
Circulation |
pmid:11940542
|
Davì G et al. |
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. |
1999 |
Circulation |
pmid:9892587
|
Cipollone F et al. |
Modulation of aspirin-insensitive eicosanoid biosynthesis by 6-methylprednisolone in unstable angina. |
2003 |
Circulation |
pmid:12515743
|
Eikelboom JW et al. |
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. |
2008 |
Circulation |
pmid:18838564
|
Larsson PT et al. |
Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. |
1994 |
Circulation |
pmid:8181117
|
Cattaneo M |
Letter by cattaneo regarding article, "incomplete inhibition of thromboxane biosynthesis by acetylsalicylic Acid: determinants and effect on cardiovascular risk". |
2009 |
Circulation |
pmid:19546394
|
Nakamura A et al. |
Oral administration of a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity for pulmonary arterial hypertension. |
2013 |
Circ. J. |
pmid:23676973
|
DeFilippis AP et al. |
Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. |
2013 |
Circ. J. |
pmid:23985963
|
Santilli F et al. |
Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding. |
2016 |
Circ. J. |
pmid:26632534
|
Gao F et al. |
Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease. |
2011 |
Chin. Med. J. |
pmid:21740787
|
Tanaka S et al. |
High dose of inhaled fluticasone reduces high levels of urinary leukotriene E4 in the early morning in mild and moderate nocturnal asthma. |
2003 |
Chest |
pmid:14605047
|
Obase Y et al. |
Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma. |
1998 |
Chest |
pmid:9792572
|
Kurokawa K et al. |
Circadian characteristics of urinary leukotriene E(4) in healthy subjects and nocturnal asthmatic patients. |
2001 |
Chest |
pmid:11742908
|
Obase Y et al. |
Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. |
2002 |
Chest |
pmid:11796443
|
Ferretti A and Flanagan VP |
Mass spectrometric evidence for the anomalous chemical behavior of 11-dehydrothromboxane B2. |
1995 |
Chem. Phys. Lipids |
pmid:7586090
|
Helgason CM et al. |
Platelet aggregation and recruitment with aspirin-clopidogrel therapy. |
2008 |
Cerebrovasc. Dis. |
pmid:18349532
|
Dippel DW et al. |
What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke? |
2004 |
Cerebrovasc. Dis. |
pmid:15026612
|
Martinuzzo ME et al. |
Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies. |
2001 |
Br. J. Haematol. |
pmid:11564073
|
Coppola A et al. |
Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype. |
2005 |
Br. J. Haematol. |
pmid:16173969
|
Wallén NH et al. |
Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris. |
1994 |
Br J Clin Pharmacol |
pmid:7946939
|
Floyd CN et al. |
Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. |
2014 |
Br J Clin Pharmacol |
pmid:25099258
|
Warner JH et al. |
Adaptive regression modeling of biomarkers of potential harm in a population of U.S. adult cigarette smokers and nonsmokers. |
2010 |
BMC Med Res Methodol |
pmid:20233412
|
Wang ZY et al. |
Comparative study of platelet activation markers in diabetes mellitus patients complicated by cerebrovascular disease. |
2001 |
Blood Coagul. Fibrinolysis |
pmid:11685040
|
Dharmasaroja PA and Sae-Lim S |
Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers. |
2010 |
Blood Coagul. Fibrinolysis |
pmid:20689403
|
Bridges AB et al. |
Circadian variation of endothelial cell function, red blood cell deformability and dehydro-thromboxane B2 in healthy volunteers. |
1991 |
Blood Coagul. Fibrinolysis |
pmid:1932530
|
Dharmasaroja PA et al. |
Aspirin nonresponders in patients with ischaemic stroke. |
2013 |
Blood Coagul. Fibrinolysis |
pmid:23429255
|
Landolfi R et al. |
Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. |
1992 |
Blood |
pmid:1327286
|